Episode Details
Back to EpisodesHighlights From ATS 2025: New and Emerging Therapies, Biomarkers, and Imaging for ILDs
Episode 524
Published 1 year, 3 months ago
Description
Drs. Zaman and Podolanczuk discuss data for new and emerging therapies for ILD presented at ATS 2025, including nerandomilast, inhaled therapies for IPF and ILD, TNIK inhibitors, as well as new biomarkers and imaging for diagnosing ILDs.